POMDOCTOR LIMITED American Depositary Shares (POM)vsScienture Holdings, Inc. (SCNX)
POM
POMDOCTOR LIMITED American Depositary Shares
$0.28
-16.24%
HEALTHCARE · Cap: $40.13M
SCNX
Scienture Holdings, Inc.
$0.46
-5.08%
HEALTHCARE · Cap: $19.69M
Smart Verdict
WallStSmart Research — data-driven comparison
POMDOCTOR LIMITED American Depositary Shares generates 56048% more annual revenue ($366.86M vs $653,390). SCNX leads profitability with a 0.0% profit margin vs -40.6%. SCNX earns a higher WallStSmart Score of 33/100 (F).
POM
Avoid28
out of 100
Grade: F
SCNX
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for POM.
Margin of Safety
+91.2%
Fair Value
$5.10
Current Price
$0.46
$4.64 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
16.2% revenue growth
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -24.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : POM
The strongest argument for POM centers on Debt/Equity, Revenue Growth. Revenue growth of 16.2% demonstrates continued momentum.
Bull Case : SCNX
The strongest argument for SCNX centers on P/E Ratio, Price/Book.
Bear Case : POM
The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.
Bear Case : SCNX
The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
POM profiles as a growth stock while SCNX is a value play — different risk/reward profiles.
POM is growing revenue faster at 16.2% — sustainability is the question.
SCNX generates stronger free cash flow (-3M), providing more financial flexibility.
Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SCNX scores higher overall (33/100 vs 28/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
POMDOCTOR LIMITED American Depositary Shares
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.
Visit Website →Scienture Holdings, Inc.
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
Scienture Holdings, Inc. (SCNX) is an innovative biotechnology company focused on developing cutting-edge therapeutic solutions for neurological disorders. With a robust drug development pipeline supported by advanced technology and a highly skilled research team, Scienture is committed to meeting unmet medical needs and improving patient outcomes. The company's strategic emphasis on scientific excellence, regulatory compliance, and collaborative partnerships positions it well for growth within the burgeoning healthcare sector, highlighting its potential to make significant contributions to global health advancements.
Compare with Other PHARMACEUTICAL RETAILERS Stocks
Want to dig deeper into these stocks?